NCT03952442

Brief Summary

Using randomized control study, explore the effect of standardized nutrition education program on the nutrition status and life quality of patients with gastric cancer after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P50-P75 for not_applicable gastric-cancer

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 16, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

1.7 years

First QC Date

May 5, 2019

Last Update Submit

May 19, 2019

Conditions

Keywords

gastric cancernutritionhealth education

Outcome Measures

Primary Outcomes (8)

  • risk of malnutrition

    Nutrition Rsik Screening 2002 is used to assess the risk of malnutrition.

    Week 0

  • risk of malnutrition

    Nutrition Rsik Screening 2002 is used to assess the risk of malnutrition.

    Week 12

  • BMI

    Body mass index is a measure of body fat based on height and weight that applies to adult men and women. It equals to weight divided by height square.

    Week 0

  • BMI

    Body mass index is a measure of body fat based on height and weight that applies to adult men and women. It equals to weight divided by height square.

    Week 12

  • albumin

    level of serum albumin

    Week 0

  • albumin

    level of serum albumin

    Week 12

  • Quality of Life (QOL)

    The QOL was measured by the European Organization for Research and Treatment quality of life version 3 questionnaire (EORTC QLQ-C30) simplified Chinese version. It contains five functional scales (physical, role, cognitive, emotional, and social), three symptoms scales (fatigue, pain, and nausea and vomiting), a global health scale, a number of single items assessing additional symptoms commonly reported by cancer patients (dyspnea, appetite loss, insomnia, constipation, and diarrhea) and financial impact of the disease. For most items, four response categories from 1 (not at all) to 4 (very much) are employed; two items (overall health, overall quality of life) have response categories ranging from 1 to 7. A high scale score represents a higher response level. Thus a high score for a functional scale, the global health status or overall QOL represents a high or healthy status or a high QOL; however, a high score for the symptom scales represents a high level of symptom.

    Week 0

  • Quality of Life (QOL)

    The QOL was measured by the European Organization for Research and Treatment quality of life version 3 questionnaire (EORTC QLQ-C30) simplified Chinese version. It contains five functional scales (physical, role, cognitive, emotional, and social), three symptoms scales (fatigue, pain, and nausea and vomiting), a global health scale, a number of single items assessing additional symptoms commonly reported by cancer patients (dyspnea, appetite loss, insomnia, constipation, and diarrhea) and financial impact of the disease. For most items, four response categories from 1 (not at all) to 4 (very much) are employed; two items (overall health, overall quality of life) have response categories ranging from 1 to 7. A high scale score represents a higher response level. Thus a high score for a functional scale, the global health status or overall QOL represents a high or healthy status or a high QOL; however, a high score for the symptom scales represents a high level of symptom.

    Week 12

Secondary Outcomes (3)

  • physical function status

    Week 0

  • physical function status

    Week 12

  • Knowledge-Attitude-Practice

    Week 12

Study Arms (2)

control group

ACTIVE COMPARATOR
Other: routine nutrition education

experimental group

EXPERIMENTAL
Other: standardized nutrition education

Interventions

Give nutrition health education every two weeks and regular survey and intervention. The education booklets are made based on the guideline and characteristics of the disease.

experimental group

Give nutrition education if the patient visits the clinics. Irregular survey and intervention were given to the patients.

control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients are diagnosed with gastric cancer and receive operation.
  • Patients need nutrition support treatment
  • Informed consent.

You may not qualify if:

  • Critical patients or stage IV
  • Patients with severe hepatic cirrhosis, Chronic Obstructive Pulmonary Disease, chronic renal failure, intestinal obstruction, stroke.
  • Unconscious or psychiatric patients
  • Patients with communication problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, 31009, China

RECRUITING

MeSH Terms

Conditions

Stomach NeoplasmsNutrition DisordersHealth Education

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesNutritional and Metabolic DiseasesAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2019

First Posted

May 16, 2019

Study Start

February 21, 2019

Primary Completion

October 30, 2020

Study Completion

December 31, 2020

Last Updated

May 21, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations